Video Experimental Relacionado

Updated: Dec 11, 2025

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

Desafíos y mejoras potenciales para el acceso de los pacientes a los productos farmacéuticos: ejemplos de la

Mitchell A Psotka¹, Mona Fiuzat², Scott D Solomon³

¹Inova Heart & Vascular Institute, Falls Church, VA (M.A.P., S.S.S., C.M.O.).

|August 25, 2020

Resumen

El acceso de los pacientes a los nuevos medicamentos se ve obstaculizado por sistemas complejos. Estandarizar las decisiones de cobertura puede mejorar el acceso y reducir la frustración de los pacientes y los médicos.

Área de la Ciencia:

Política de salud
Economía farmacéutica
Acceso de los pacientes a los medicamentos

Sus antecedentes:

El acceso de los pacientes a los medicamentos después de la aprobación reguladora de los Estados Unidos implica una intrincada red de pagadores, administradores de beneficios de farmacia, distribuidores, fabricantes, sistemas de salud y farmacias.
Las recientes aprobaciones de nuevas terapias revelan complejidades en los canales de distribución de medicamentos.
Si bien las estrategias de gestión de la utilización tienen como objetivo controlar el aumento del gasto en atención médica y farmacéutica, a menudo carecen de transparencia y pueden tener un impacto desproporcionado en las poblaciones vulnerables.

Objetivo del estudio:

Analizar el panorama actual del seguro de salud e identificar mecanismos para mejorar el acceso de los pacientes a medicamentos adecuados.
Para reducir la frustración de los pacientes y los médicos en el mercado farmacéutico.
Proponer un sistema más eficiente y equitativo para el acceso a los medicamentos.

Principales métodos:

Análisis del panorama actual del seguro de salud y de la distribución farmacéutica.
Examen de las prácticas actuales de gestión de la utilización y su impacto.
Formulación de recomendaciones para la reforma de los procesos.

Principales resultados:

Los sistemas actuales presentan importantes obstáculos administrativos para el acceso de los pacientes.
La falta de transparencia en las decisiones de cobertura y la gestión de la utilización es frecuente.
Las poblaciones vulnerables pueden enfrentar desafíos de acceso desproporcionados.

Conclusiones:

Se necesita un proceso compartido, estandarizado y transparente para las decisiones de cobertura de medicamentos.
Las reformas deben dar prioridad a las pruebas clínicas y de rentabilidad.
Los cambios propuestos pueden beneficiar a los pacientes y mejorar la eficiencia del sistema farmacéutico.

Palabras clave:

Enfermedades cardiovasculares recetas para medicamentos seguro de salud insuficiencia cardíaca Autorización previa

Más Videos Relacionados

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Videos de Conceptos Relacionados

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Bioavailability Enhancement: Drug Permeability Enhancement

Bioavailability Enhancement: Drug Permeability Enhancement

Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...

Issues And Trends In Healthcare Delivery System

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...